Study Status
Re-verified, no change to tracked fields
v20
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00463099 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialStudy Status
Re-verified, no change to tracked fields
v20
Primary completion date: Dec 2026 to Dec 2027
Completion date: Dec 2027 to Dec 2028
Study Statusv19
Primary completion date: May 2021 to Dec 2026
Trial status: Completed to Active, Not Recruiting; Completion date: Dec 2021 to Dec 2027; Eligibility criteria shortened, about 36 words; and 2 more
Study Status, Study Description, Outcome Measures, Eligibilityv18
Study Status
Re-verified, no change to tracked fields
v17
Study sites revised (8)
Study Status, Contacts/Locationsv16
Trial status: Active, Not Recruiting to Completed
Enrollment target: estimated 5000 to confirmed 3294; Primary completion date changed from estimate of Dec 2023 to May 2021; Study completion date changed from estimate of Dec 2024 to Dec 2021
Study Status, Study Designv15
2 amendments
2 re-verifications since 2020-04-23, no change to tracked fields
v13-v14
Study sites: 10 to 8
Study Status, Contacts/Locationsv12
Lead sponsor: Vanderbilt University to Vanderbilt University Medical Center
Study sites: 9 to 10
Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locationsv11
Primary completion date: Dec 2016 to Dec 2023
Completion date: Dec 2017 to Dec 2024; Start date: Jan 2007 to Jan 2002
Study Status, Sponsor/Collaborators, IPDSharingv10
Study description expanded, about 3 words
Study Status, Study Description, Eligibilityv9
Trial status: Enrolling by Invitation to Active, Not Recruiting
Study Statusv8
Primary completion date: Dec 2016
Completion date: Dec 2016 to Dec 2017; Study description expanded, about 4 words
Study Identification, Study Status, Sponsor/Collaborators, Study Description, Outcome Measuresv7
Eligibility criteria expanded, about 21 words
Study Identification, Study Status, Conditions, Eligibilityv6
Collaborators: 1 to 2
Study Identification, Study Status, Sponsor/Collaboratorsv5
Eligibility criteria shortened, about 14 words
Study Status, Eligibilityv4
Eligibility criteria shortened, about 9 words
Study title shortened, about 1 word
Study Identification, Study Status, Eligibilityv3
Trial status: Recruiting to Enrolling by Invitation
Site details revised at 9 of 9 sites
Study Status, Sponsor/Collaborators, Study Design, Eligibility, Contacts/Locationsv2
Study First Submitted
| NCT Number | NCT00463099 |
| Lead Sponsor | Vanderbilt University Medical Center
Collaborators: National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
| Conditions | Rupture of Anterior Cruciate Ligament |
| Enrollment | 3,294 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |